Trials / Completed
CompletedNCT02302365
Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion
Multicenter, Retrospective Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- Terumo BCT · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, retrospective data collection of routine clinical use with the Spectra Optia® apheresis system for white blood cell depletion.
Detailed description
The goal of this study is to gather a broader knowledge and information from routine clinical use on the performance and safety of white blood cell depletion procedures with the Spectra Optia® apheresis system. In order to do so, retrospective data on white blood cell depletion procedures with the Spectra Optia® apheresis system done in routine use in 3 different centers will be collected and analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spectra Optia® Apheresis System | White Blood Cell Depletion |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2014-11-27
- Last updated
- 2018-07-03
- Results posted
- 2016-03-03
Locations
3 sites across 3 countries: Belgium, Germany, Hungary
Source: ClinicalTrials.gov record NCT02302365. Inclusion in this directory is not an endorsement.